The Group obtains approval of the Cetilar® patent in the USA and new prospects unfold for SiderAL® in India thanks to […]
International recognition continues for PharmaNutra, which, whilst commercially experiencing a strong and constant expansion in foreign markets, also continues, from […]
The new patent, valid until 2037, opens PharmaNutra up to the possibility of developing specific products for the cardiovascular field, […]
After Europe, the intellectual property rights of the patent expiring in 2033 are now acknowledged in the United States. A […]
Sorry, this entry is only available in Italiano. Il convegno scientifico internazionale dedicato alle lesioni tendinee in ambito sportivo, tenutosi […]
Sorry, this entry is only available in Italiano. Il convegno scientifico dedicato alle lesioni tendinee in ambito sportivo si terrà […]
Pharmanutra presented seven new posters dedicated to oral iron research at the International BioIron Society 2019. The eighth edition […]
During the conference “Medicine Medicine meets the universe of sports”, PharmaNutra presented its two leading brands, SiderAL® and Cetilar®, as […]
Last week PharmaNutra attended the NATA Symposium 2019, the twentieth edition of the most important European event dedicated to transfusion […]
A truly international success characterized by a multidisciplinary approach: this is the outcome of the 7th Edition of the International […]
Sorry, this entry is only available in Italiano. Gli interventi della prima giornata saranno focalizzati sulla carenza di ferro in […]
Sorry, this entry is only available in Italiano. PharmaNutra e Zambon presentano la 7ma edizione dell’IMCID, che si aprirà questo […]